149 related articles for article (PubMed ID: 8445064)
1. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis.
Duhra P
J Am Acad Dermatol; 1993 Mar; 28(3):466-9. PubMed ID: 8445064
[TBL] [Abstract][Full Text] [Related]
2. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
Prey S; Paul C
Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
[TBL] [Abstract][Full Text] [Related]
3. Folate supplementation during methotrexate therapy for patients with psoriasis.
Strober BE; Menon K
J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
[TBL] [Abstract][Full Text] [Related]
4. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
6. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.
Baran W; Batycka-Baran A; Zychowska M; Bieniek A; Szepietowski JC
Expert Opin Drug Saf; 2014 Aug; 13(8):1015-21. PubMed ID: 24972718
[TBL] [Abstract][Full Text] [Related]
7. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
[TBL] [Abstract][Full Text] [Related]
8. The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom.
Kirby B; Lyon CC; Griffiths CE; Chalmers RJ
Clin Exp Dermatol; 2000 Jun; 25(4):265-8. PubMed ID: 10971481
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate in psoriasis: do we need to give a test dose?
Carretero-Hernández G
Actas Dermosifiliogr; 2012 Jan; 103(1):1-4. PubMed ID: 22440152
[No Abstract] [Full Text] [Related]
10. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
[TBL] [Abstract][Full Text] [Related]
11. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and methotrexate therapy for psoriasis.
Hughes R; Harries M; Chalmers RJ; Kirby B
J Am Acad Dermatol; 2006 Aug; 55(2):366-7. PubMed ID: 16844540
[No Abstract] [Full Text] [Related]
13. Does daily folic acid supplementation reduce methotrexate efficacy?
Cline A; Jorizzo JL
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447631
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate revisited: effects of long-term treatment in psoriasis.
Van Dooren-Greebe RJ; Kuijpers AL; Mulder J; De Boo T; Van de Kerkhof PC
Br J Dermatol; 1994 Feb; 130(2):204-10. PubMed ID: 8123573
[TBL] [Abstract][Full Text] [Related]
15. Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
Temtem TA; Vickers M; Whitworth J
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049427
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis.
Campalani E; Arenas M; Marinaki AM; Lewis CM; Barker JN; Smith CH
J Invest Dermatol; 2007 Aug; 127(8):1860-7. PubMed ID: 17410198
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
18. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
Hendel J; Poulsen H; Nyfors B; Nyfors A
Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):321-6. PubMed ID: 4024960
[TBL] [Abstract][Full Text] [Related]
19. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment.
Refsum H; Helland S; Ueland PM
Clin Pharmacol Ther; 1989 Nov; 46(5):510-20. PubMed ID: 2582708
[TBL] [Abstract][Full Text] [Related]
20. Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis.
Pincus T
Clin Exp Rheumatol; 1998; 16(6):667-8. PubMed ID: 9844757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
